One of the best ways to track a conference’s tone is to take to the Twitters. At this week’s Cleveland Clinic Medical Innovation Summit, there was much to be said:
“The days of us claiming value and not being able to deliver on that are numbered – Myriad’s Mark Capone on genetic testing #MIS2014
— Medical Device Daily (@MedDevicesDaily) October 28, 2014
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
.@ClevelandClinic‘s CIO C. Martin Harris: Cleveland Clinic has 300 core systems that have to be coordinated. #MIS2014 #interoperability
— Erin McCann (@EMcCannHITN) October 28, 2014
45 pitches, 59 seconds a piece. Like a delicious popcorn bucket full of buttered and brilliant medical startups. #MIS2014
— mollypopp (@mollypopp) October 28, 2014
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Bundled payments may help drive innovative therapy or delivery. No financial incentive for shorter course of radiation. Khuntia at #MIS2014
— Dale Shepard MD, PhD (@ShepardDale) October 28, 2014
Developing genomic profiles early in cancer treatment will likely be beneficial in a bundled pay system. Dr. Vincent Miller at #MIS2014
— Dale Shepard MD, PhD (@ShepardDale) October 28, 2014
